Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Doxorubicin, cyclophosphamide
DRUG
2 trials
Sponsors
The Netherlands Cancer Institute
, Peking Union Medical College Hospital
Conditions
Breast Cancer
Phase 2
Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer
Active, not recruiting
NCT01057069
The Netherlands Cancer Institute
Breast Cancer
Start: 2010-01-31
End: 2029-12-31
Updated: 2022-10-12
AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer
NCT01415336
Peking Union Medical College Hospital
Breast Cancer
Start: 2010-03-31
Target: 300
Updated: 2011-08-11
Related Papers
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial.
2023-09-09
5 citations
Decisions on Further Research for Predictive Biomarkers of High-Dose Alkylating Chemotherapy in Triple-Negative Breast Cancer: A Value of Information Analysis.
2016-04-06
11 citations
Early stage cost-effectiveness analysis of a BRCA1-like test to detect triple negative breast cancers responsive to high dose alkylating chemotherapy.
2015-04-28
9 citations